Glenmark wins U.S. approval for mometasone, metformin doses

05/30/2008 | Business Standard (India)

Glenmark Pharmaceuticals unit Glenmark Generics has secured final approval from the FDA for new strengths of mometasone furoate topical treatments, as well as new dosages of metformin hydrochloride tablets -- the generic version of Bristol-Myers Squibb Co.'s diabetes drug Glucophage. The products will be launched in the U.S. soon, the Indian drug firm said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC